Research on Association Between Selenium Deficiencies and Change of Thyroid Function
Effect of Selenium Deficiency on Thyroid Function
1 other identifier
observational
200
1 country
1
Brief Summary
As one of the essential micronutrients, selenium has important biological functions. However, an effective and convenient method for evaluation of selenium nutritional status has not yet been established. Previous literature has disclosed effect of selenium deficiency on inactivating glutathion peroxidase and deiodinase, which may cause decreased conversion from thyroxine ( T4) to triiodothyronine (T3). A case-control study is designed to demonstrate the association between selenium deficiency and abnormally elevated T4 or T4/T3, which may provide more clues for establishing effective selenium assesment methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2018
CompletedFirst Posted
Study publicly available on registry
February 28, 2018
CompletedStudy Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedMay 23, 2018
May 1, 2018
9 months
February 7, 2018
May 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
between-group difference in serum selenium
comparison of the mean serum selenium between the two groups
up to 24 weeks
Secondary Outcomes (2)
between-group difference in serum deiodinase activity
up to 24 weeks
between-group difference in erythrocyte glutathione peroxidase activity
up to 24 weeks
Study Arms (2)
group with normal T4 level or T4/T3
participants with T4 within 4.3-12.5ug/dl and ratio of T4/T3(T4(ug/dl)/T3 (ng/ml)) ≤7.52, which are considered to be normal T4 level and T4/T3.
group with elevated T4 level or T4/T3
participants with T4 more than 12.5ug/dl and ratio of T4/T3(T4(ug/dl)/T3 (ng/ml)) \> 7.52, which are considered to be elevated T4 level and T4/T3.
Interventions
For this case-control study, no intervention will be administered to participants, only serum sample will be collected for selenium assessment
Eligibility Criteria
Study participants will be recruited from volunteers who undergo health examination in Peking Union Medical College Hospital and meet the inclusion criteria.
You may qualify if:
- with normal free triiodothyronine( FT3), free thyroxine (FT4) and thyroid-stimulating hormone (TSH).
- without thyroid hormone replacement therapy
- without medical history of thyroid surgery
- without iodine radiotherapy;
You may not qualify if:
- acute critical illness in the latest 1 year;
- weight fluctuation by more than 5% in the latest 3 months;
- eating disorders
- neuropsychological disorders
- allergy to corn or yeast
- fail to give informed consents.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Biospecimen
serum
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dietitian
Study Record Dates
First Submitted
February 7, 2018
First Posted
February 28, 2018
Study Start
April 1, 2018
Primary Completion
December 31, 2018
Study Completion
April 1, 2019
Last Updated
May 23, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share